Literature DB >> 25183364

Empowering the child and caregiver: yellow zone Asthma Action Plan.

Chitra Dinakar1, Jay M Portnoy.   

Abstract

Current guidelines, both national and international, elegantly describe evidence-based measures to attain and maintain long-term control of asthma. These strategies, typically discussed between the provider and patient, are provided in the form of written (or electronic) instructions as part of the green zone of the color-coded Asthma Action Plan. The red zone of the Asthma Action Plan has directives on when to use systemic corticosteroids and seek medical attention. The transition zone between the green zone of good control and the red zone of asthma exacerbation is the yellow zone. This zone guides the patient on self-management of exacerbations outside a medical setting. Unfortunately, the only recommendation currently available to patients per the current asthma guidelines is the repetitive use of reliever bronchodilators. This approach, while providing modest symptom relief, does not reliably prevent progression to the red zone. In this document, we present new, evidence-based, yellow zone intervention options.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25183364     DOI: 10.1007/s11882-014-0475-z

Source DB:  PubMed          Journal:  Curr Allergy Asthma Rep        ISSN: 1529-7322            Impact factor:   4.806


  43 in total

1.  Effect of budesonide in combination with formoterol for reliever therapy in asthma exacerbations: a randomised controlled, double-blind study.

Authors:  Klaus F Rabe; Tito Atienza; Pál Magyar; Per Larsson; Carin Jorup; Umesh G Lalloo
Journal:  Lancet       Date:  2006-08-26       Impact factor: 79.321

2.  First-line therapy for adult patients with acute asthma receiving a multiple-dose protocol of ipratropium bromide plus albuterol in the emergency department.

Authors:  G J Rodrigo; C Rodrigo
Journal:  Am J Respir Crit Care Med       Date:  2000-06       Impact factor: 21.405

3.  Exacerbations of asthma: a descriptive study of 425 severe exacerbations. The FACET International Study Group.

Authors:  A E Tattersfield; D S Postma; P J Barnes; K Svensson; C A Bauer; P M O'Byrne; C G Löfdahl; R A Pauwels; A Ullman
Journal:  Am J Respir Crit Care Med       Date:  1999-08       Impact factor: 21.405

4.  Low-dose budesonide with the addition of an increased dose during exacerbations is effective in long-term asthma control. On behalf of the Italian Study Group.

Authors:  A Foresi; M C Morelli; E Catena
Journal:  Chest       Date:  2000-02       Impact factor: 9.410

5.  Budesonide/formoterol combination therapy as both maintenance and reliever medication in asthma.

Authors:  Paul M O'Byrne; Hans Bisgaard; Philippe P Godard; Massimo Pistolesi; Mona Palmqvist; Yuanjue Zhu; Tommy Ekström; Eric D Bateman
Journal:  Am J Respir Crit Care Med       Date:  2004-10-22       Impact factor: 21.405

6.  Efficacy and safety of budesonide/formoterol single inhaler therapy versus a higher dose of budesonide in moderate to severe asthma.

Authors:  R Scicchitano; R Aalbers; D Ukena; A Manjra; L Fouquert; S Centanni; L-P Boulet; I P Naya; C Hultquist
Journal:  Curr Med Res Opin       Date:  2004-09       Impact factor: 2.580

7.  Influence of dosing frequency and schedule on the response of chronic asthmatics to the aerosol steroid, budesonide.

Authors:  J H Toogood; J C Baskerville; B Jennings; N M Lefcoe; S A Johansson
Journal:  J Allergy Clin Immunol       Date:  1982-10       Impact factor: 10.793

8.  Early intervention with high-dose inhaled corticosteroids for control of acute asthma exacerbations at home and improved outcomes: a randomized controlled trial.

Authors:  Ejaz Yousef; Jobayer Hossain; Susan Mannan; Edward Skorpinski; Stephen McGeady
Journal:  Allergy Asthma Proc       Date:  2012 Nov-Dec       Impact factor: 2.587

9.  Factors associated with asthma exacerbations during a long-term clinical trial of controller medications in children.

Authors:  Ronina A Covar; Stanley J Szefler; Robert S Zeiger; Christine A Sorkness; Mark Moss; David T Mauger; Susan J Boehmer; Robert C Strunk; Fernando D Martinez; Lynn M Taussig
Journal:  J Allergy Clin Immunol       Date:  2008-10       Impact factor: 10.793

10.  Dose of cat (Felis domesticus) allergen 1 (Fel d 1) that induces asthma.

Authors:  T E Van Metre; D G Marsh; N F Adkinson; J E Fish; A Kagey-Sobotka; P S Norman; E B Radden; G L Rosenberg
Journal:  J Allergy Clin Immunol       Date:  1986-07       Impact factor: 10.793

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.